Practice
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Nextracker spinoff from Flex
We advised Nextracker on its spinoff
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Nuvei $6.3 billion going-private acquisition
We are advising Nuvei on the transaction
AnHeart Therapeutics acquisition by Nuvation Bio
We are advising AnHeart Therapeutics on the acquisition
Narragansett Electric $500 million senior notes offering
We advised the company on the transaction
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Reddit $748 million IPO
The shares are listed on the New York Stock Exchange
REV Group $127.5 million secondary offering
We advised REV Group on its SEC-registered secondary stock offering
Trial Holdings ¥44.6 billion IPO
The shares are listed on the Tokyo Stock Exchange
Crane NXT $270 million acquisition of OpSec Security
We are advising Crane NXT on the acquisition
Rubicon closes approximately $1.18B fundraise for second flagship PE fund
We advised Rubicon on the fundraise
SMFG $1 billion perpetual subordinated notes offering
We advised SMFG on its SEC-registered offering of Additional Tier 1 notes